The PSIP project for Adverse Drug Events prevention

被引:1
|
作者
Bernonville, S. [1 ]
Guillot, B. [2 ]
Pedersen, H. G. [3 ]
Koutkias, V. [4 ]
Beuscart, R. [1 ]
机构
[1] CHU Lille, UDSL EA 2694, F-59000 Lille, France
[2] MEDASYS, F-91193 Gif Sur Yvette, France
[3] IBM Denmark ApS, IBM Global Business Serv, Healthcare, DK-2800 Lyngby, Denmark
[4] Aristotle Univ Thessaloniki, Sch Med, Lab Med Informat, Thessaloniki 54124, Greece
关键词
D O I
10.1016/j.irbm.2013.09.001
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The objective of Clinical Decision Support (CDSS) systems coupled with Computerised Physician Order Entry (CPOE) systems is to improve patient safety. However, there are still issues to be considered to improve the quality of CDSS, especially the difficulty to share the knowledge developed by institutions or healthcare organisations and to exploit it for other medical application. The aim of the Patient Safety through Intelligent Procedures (PSIP) project is to propose innovative tools to generate and provide relevant knowledge to healthcare professionals and patients for Adverse Drug Events (ADE) prevention. The particularity of the PSIP project is to consider the share of knowledge and the interoperability of medical applications via the elaboration of a Global Knowledge Platform (GKP). In this paper, we present the different components of the PSIP GKP and we show its implementation through three medical applications: a web application, an Electronic Health Record (EHR) and a CPOE. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 50 条
  • [31] Reporting Adverse Drug Events
    Feagins, Linda A.
    Abdelsayed, George G.
    Schairer, Jason
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1411 - 1413
  • [32] Adverse drug events in the elderly
    Cresswell, Kathrin M.
    Fernando, Bernard
    McKinstry, Brian
    Sheikh, Aziz
    [J]. BRITISH MEDICAL BULLETIN, 2007, 83 (01) : 259 - 274
  • [33] Yohimbine adverse drug events
    Tu, N. N.
    Haller, C. A.
    Kearney, T. E.
    [J]. CLINICAL TOXICOLOGY, 2007, 45 (06): : 625 - 625
  • [34] PREVENTING ADVERSE DRUG EVENTS
    LEAPE, LL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (04) : 379 - 382
  • [35] Preventing adverse drug events
    Davidson, Ann
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (01) : 67 - 68
  • [36] The burden of adverse drug events
    Breckenridge, Alasdair
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 785 - 787
  • [37] Monitoring for adverse drug events
    Kennedy, DL
    Goldman, SA
    [J]. AMERICAN FAMILY PHYSICIAN, 1997, 56 (07) : 1718 - &
  • [38] Management of adverse drug events
    Jaehde, U.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 75 - 76
  • [39] Adverse drug events costly
    不详
    [J]. NURSING ECONOMICS, 1997, 15 (06): : 318 - 318
  • [40] Hypomagnesemia and exposure to romidepsin: A Research on Adverse Drug events and Reports (RADAR) project.
    Lee, Dylan E.
    Serrano, Linda
    Martinez-Escala, Estela
    Kaplan, Jason B.
    Pro, Barbara
    Guitart, Joan
    Temps, William H.
    West, Dennis P.
    Belknap, Steven M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35